Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Corticosteroides orales iniciados por el paciente y por los padres para las exacerbaciones del asma

Información

DOI:
https://doi.org/10.1002/14651858.CD012195.pub2Copiar DOI
Base de datos:
  1. Cochrane Database of Systematic Reviews
Versión publicada:
  1. 12 diciembre 2016see what's new
Tipo:
  1. Intervention
Etapa:
  1. Review
Grupo Editorial Cochrane:
  1. Grupo Cochrane de Vías respiratorias

Copyright:
  1. Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Cifras del artículo

Altmetric:

Citado por:

Citado 0 veces por enlace Crossref Cited-by

Contraer

Autores

  • Muhammad B Ganaie

    Respiratory Medicine, Royal Stoke University Hospital, Stoke‐on‐Trent, UK

  • M Munavvar

    Respiratory Medicine, Lancashire Teaching Hospitals NHS Foundation Trust, Preston, UK

  • Morris Gordon

    School of Medicine and Dentistry, University of Central Lancashire, Preston, UK

    Families Division, Blackpool Victoria Hospital, Blackpool, UK

  • Hui F Lim

    National University Health System, Division of Respiratory & Critical Care Medicine, Singapore City, Singapore

  • David JW Evans

    Correspondencia a: Lancaster Health Hub, Lancaster University, Lancaster, UK

    [email protected]

Contributions of authors

All review authors contributed to the drafting of the review, reviewed it critically for intellectual content, provided final approval of the version to be published and are accountable for all aspects of the work.

Sources of support

Internal sources

  • The authors declare that no such funding was received for this systematic review, UK.

External sources

  • David Evans, UK.

    National Institute for Health Research (NIHR): Evidence to guide care in adults and children with asthma, 13/89/14

Declarations of interest

MB Ganaie: none known.

M Munavvar: none known.

M Gordon: none known.

HF Lim: none known.

D Evans: provides freelance writing services to medical communication agencies.

Acknowledgements

The Background and Methods sections of this review are based on a standard template used by Cochrane Airways. We thank Elizabeth Stovold for designing the search strategy, and Rebecca Normansell and Emma Welsh for their contribution to the content and methodology of the review.

Rebecca Normansell was the contact editor for this review and commented critically on the review.

Version history

Published

Title

Stage

Authors

Version

2016 Dec 12

Patient‐ and parent‐initiated oral steroids for asthma exacerbations

Review

Muhammad B Ganaie, M Munavvar, Morris Gordon, Hui F Lim, David JW Evans

https://doi.org/10.1002/14651858.CD012195.pub2

2016 May 16

Patient‐ and parent‐initiated oral steroids for asthma exacerbations

Protocol

Muhammad B Ganaie, M Munavvar, Morris Gordon, David JW Evans

https://doi.org/10.1002/14651858.CD012195

Differences between protocol and review

The review was performed as per the protocol. We substituted one of the secondary outcomes for health‐related quality of life as the outcome in question (asthma control) was already included as a primary outcome.

Keywords

MeSH

PICO

Population
Intervention
Comparison
Outcome

El uso y la enseñanza del modelo PICO están muy extendidos en el ámbito de la atención sanitaria basada en la evidencia para formular preguntas y estrategias de búsqueda y para caracterizar estudios o metanálisis clínicos. PICO son las siglas en inglés de cuatro posibles componentes de una pregunta de investigación: paciente, población o problema; intervención; comparación; desenlace (outcome).

Para saber más sobre el uso del modelo PICO, puede consultar el Manual Cochrane.

Study flow diagram.
Figuras y tablas -
Figure 1

Study flow diagram.

Summary of findings for the main comparison. Summary of findings: patient‐initiated steroids

Patient‐initiated steroids compared with placebo/normal care/alternative active treatment for asthma

Patient or population: adults aged 18 years or older with asthma

Settings: outpatient

Intervention: patient‐initiated oral corticosteroids

Comparison: placebo/normal care/alternative active treatment

Outcomes

Number of participants
(studies)

Comments

Hospital admissions for asthma

0 (0 studies)

No studies met the inclusion criteria for this review

Asthma control (validated scales)

0 (0 studies)

Serious adverse events (all cause)

0 (0 studies)

Unscheduled visit to a healthcare provider

0 (0 studies)

Health‐related quality of life (validated scales)

0 (0 studies)

Days lost of study/work

0 (0 studies)

Adverse events (all cause)

0 (0 studies)

GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate
Very low quality: We are very uncertain about the estimate

Figuras y tablas -
Summary of findings for the main comparison. Summary of findings: patient‐initiated steroids
Summary of findings 2. Summary of findings: parent‐initiated steroids

Parent‐initiated steroids compared with placebo/normal care/alternative active treatment for asthma

Patient or population: children aged 5 years or older with asthma

Settings: outpatient

Intervention: parent‐initiated oral corticosteroids

Comparison: placebo/normal care/alternative active treatment

Outcomes

Number of participants
(studies)

Comments

Hospital admissions for asthma

0 (0 studies)

No studies met the inclusion criteria for this review

Asthma control (validated scales)

0 (0 studies)

Serious adverse events (all cause)

0 (0 studies)

Unscheduled visit to a healthcare provider

0 (0 studies)

Health‐related quality of life (validated scales)

0 (0 studies)

Days off school

0 (0 studies)

Adverse events (all cause)

0 (0 studies)

GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate
Very low quality: We are very uncertain about the estimate

Figuras y tablas -
Summary of findings 2. Summary of findings: parent‐initiated steroids